Navigation Links
LA Tumor Registry at LSUHSC receives $1.3 million from NCI
Date:8/6/2013

New Orleans, LA The Louisiana Tumor Registry (LTR) at the LSU Health Sciences Center New Orleans School of Public Health has been awarded a $1.3 million contract by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. There are 18 competitively awarded SEER cancer registries in the United States.

"The SEER Program is the most authoritative source of information on cancer incidence and survival in the United States," said Dr. Elizabeth Fontham, Dean of the LSUHSC-NOLA School of Public Health. "Continued designation recognizes the excellence of our Louisiana Tumor Registry and confirms the exceptionally high quality of its data."

The SEER Program collects cancer incidence and survival data from 18 population-based cancer registries covering about 28% of the U.S. population. It is considered to be the standard for quality among cancer registries around the world. Quality control has been an integral part of SEER since its inception.

Cancer is a reportable disease in the State of Louisiana. Hospitals, private pathology laboratories, radiation centers, physicians, nursing homes, hospices, other licensed health care facilities and providers who diagnose and/or treat cancers are required by law to report cancer cases to the LTR. The Registry includes the central office located at the LSU Health Sciences Center New Orleans and eight regional offices. Each regional registry is responsible for ascertaining all cancer cases from all possible sources in its region. The central office provides training, ensures high quality data by consolidating and editing records of abstracts, and manages statewide database, as well as analyzes the data and conducts special studies.

The primary function of a cancer registry is to record the occurrence of cancer in a population. To achieve this goal, the LTR has established inter-state data exchange programs with nineteen states to receive data on Louisiana cancer patients who are diagnosed and/or treated at out-of-state facilities. Information collected by LTR includes demographic data, tumor type, stage of disease, tumor markers, treatment, and survival. Information on risk factors is usually not available from the reporting sources. However, data from the registry often provides clues to be pursued in special research studies conducted by qualified scientists with external funding.

In 1995, the Louisiana Tumor Registry was transferred from the Louisiana Office of Public Health to the LSU Health Sciences Center New Orleans. Since then, the Louisiana Tumor Registry at LSU Health Sciences Center has received strong and continued institutional support that has translated into impressive productivity and federal funding. Achievements include the first place award on its data quality profiles from the NCI SEER Program consecutively from 2010 to 2012 and a gold certification award on its data quality from North American Association of Central Cancer Registries (NAACCR) every year since 1995. In 2012, LTR received the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR) 20th Anniversary Research Award for its scientific and epidemiologic soundness of study designs, innovative use of central cancer registry data, quality and number of scientific outcomes (peer-reviewed papers, posters, and abstracts resulting from research), and potential or actual impact on cancer early detection, diagnosis, or treatment that will lead to improved outcomes or contributions to knowledge about cancer causes or control. In addition to routine data collection, the LTR has built infrastructures and collected data to support all types of cancer research studies from etiology study, cancer prevention, linkage study, patterns of care study, comparative effectiveness research, and patient outcome study to survivorship study.

"This funding allows us to continue providing Louisiana citizens, health professionals, policy makers and others required information for cancer prevention and control, and building infrastructures and capacities to support more cancer research, including cancer care delivery research," notes Xiao Cheng Wu, MD, MPH, LSUHSC Associate Professor of Epidemiology, Director of the Louisiana Tumor Registry, and Principal Investigator of this NCI contract. "Our data are used for prevention, early detection, treatment, and survival which, in turn, contribute to the development of national policy and efforts."


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related medicine news :

1. Tumor cell vaccination trial to promote anti-leukemia responses
2. Immune system molecule promotes tumor resistance to anti-angiogenic therapy
3. Suffocating tumors could lead to new cancer drugs
4. Digital PCR technology detects brain-tumor-associated mutation in cerebrospinal fluid
5. Protein complex linked to cancer growth may also help fight tumors, Moffitt researchers say
6. Voices Against Brain Cancer Comments on Discovery of Nano Drug That May Aid in Treatment of Brain Tumors
7. Compounds outsmart solid tumors malfunctioning machinery
8. Nano drug crosses blood-brain tumor barrier, targets brain-tumor cells and blood vessels
9. Self-perpetuating signals may drive tumor cells to spread
10. Suspicions confirmed: Brain tumors in children have a common cause
11. American Brain Tumor Association Conference to Help Patients/Caregivers Map Road to Wellness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2020)... ... 2020 , ... National Association of Chain Drug Stores (NACDS) ... nation’s ongoing preparations for the eventual deployment of COVID-19 vaccines: , “By any ... essential component of vaccine deployment. They will need to be part of the ...
(Date:7/22/2020)... ... 2020 , ... As part of August’s Children’s Eye Health and Safety Month, and as a ... at Prevent Blindness (NCCVEH) has released an updated version of the report titled ... goal of the report is , to provide updated surveillance ...
(Date:7/22/2020)... , ... July 22, 2020 , ... ... unique opioid related compositions of matter and manufacturing processes from Brock University for ... auction lot 114 , sold by Brock University provides the manufacturing processes of ...
(Date:7/22/2020)... ... July 22, 2020 , ... Healthcare data curation ... Data Curation as a Service (DCaaS) solution for payers, providers, healthcare systems, and ... data curation parameters and are custom tailored to provide clients a clear, trusted, ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... an Honorable Mention in the Hermes Creative Awards, was a charitable push put ... spread positivity to contrast the news during the pandemic, HMI asked individuals in ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... July 31, 2020 , ... In an informal poll of ... majority voted for a refreshed Minnesota Twins “Minnie and Paul” logo that is more ... circa 1960. That was well before the civil rights movement in the United States. ...
(Date:7/22/2020)... Pa. (PRWEB) , ... July 22, 2020 , ... ... agency for the nation’s top healthcare companies and part of WPP (NYSE:WPP), has ... Warren, EVP, Media Investment. , As the agency ventures further into healthcare consumer ...
(Date:7/10/2020)... ... July 10, 2020 , ... ... and advanced manufacturing solutions provider today announced that their CANSWAB™ nasopharyngeal swabs are ... Company has engineered a new 3D-printed swab design and has trademarked the name ...
Breaking Medicine Technology: